Literature DB >> 27760874

Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria.

Emily C Edmonds1, Joel Eppig2, Mark W Bondi2, Kelly M Leyden2, Bailey Goodwin2, Lisa Delano-Wood2, Carrie R McDonald2.   

Abstract

OBJECTIVE: We investigated differences in regional cortical thickness between previously identified empirically derived mild cognitive impairment (MCI) subtypes (amnestic MCI, dysnomic MCI, dysexecutive/mixed MCI, and cluster-derived normal) in order to determine whether these cognitive subtypes would show different patterns of cortical atrophy.
METHODS: Participants were 485 individuals diagnosed with MCI and 178 cognitively normal individuals from the Alzheimer's Disease Neuroimaging Initiative. Cortical thickness estimates were computed for 32 regions of interest per hemisphere. Statistical group maps compared each MCI subtype to cognitively normal participants and to one another.
RESULTS: The pattern of cortical thinning observed in each MCI subtype corresponded to their cognitive profile. No differences in cortical thickness were found between the cluster-derived normal MCI subtype and the cognitively normal group. Direct comparison between MCI subtypes suggested that the cortical thickness patterns reflect increasing disease severity.
CONCLUSIONS: There is an ordered pattern of cortical atrophy among patients with MCI that coincides with their profiles of increasing cognitive dysfunction. This heterogeneity is not captured when patients are grouped by conventional diagnostic criteria. Results in the cluster-derived normal group further support the premise that the conventional MCI diagnostic criteria are highly susceptible to false-positive diagnostic errors. Findings suggest a need to (1) improve the diagnostic criteria by reducing reliance on conventional screening measures, rating scales, and a single memory measure in order to avoid false-positive errors; and (2) divide MCI samples into meaningful subgroups based on cognitive and biomarkers profiles-a method that may provide better staging of MCI and inform prognosis.
© 2016 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27760874      PMCID: PMC5109943          DOI: 10.1212/WNL.0000000000003326

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Gray matter atrophy patterns of mild cognitive impairment subtypes.

Authors:  Haobo Zhang; Perminder S Sachdev; Wei Wen; Nicole A Kochan; John D Crawford; Henry Brodaty; Melissa J Slavin; Simone Reppermund; Brian Draper; Wanlin Zhu; Kristan Kang; Julian N Trollor
Journal:  J Neurol Sci       Date:  2012-01-26       Impact factor: 3.181

3.  Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease.

Authors:  Vivek Singh; Howard Chertkow; Jason P Lerch; Alan C Evans; Adrienne E Dorr; Noor Jehan Kabani
Journal:  Brain       Date:  2006-09-28       Impact factor: 13.501

4.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

5.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Alterations in cortical thickness and white matter integrity in mild cognitive impairment measured by whole-brain cortical thickness mapping and diffusion tensor imaging.

Authors:  L Wang; F C Goldstein; E Veledar; A I Levey; J J Lah; C C Meltzer; C A Holder; H Mao
Journal:  AJNR Am J Neuroradiol       Date:  2009-03-11       Impact factor: 3.825

8.  Cortical thickness in single- versus multiple-domain amnestic mild cognitive impairment.

Authors:  Sang Won Seo; Kiho Im; Jong-Min Lee; Yun-Hee Kim; Sung Tae Kim; Seong Yoon Kim; Dong Won Yang; Sun I Kim; Yoon Sun Cho; Duk L Na
Journal:  Neuroimage       Date:  2007-03-13       Impact factor: 6.556

9.  Cortical Amyloid Burden Differences Across Empirically-Derived Mild Cognitive Impairment Subtypes and Interaction with APOE ɛ4 Genotype.

Authors:  Katherine J Bangen; Alexandra L Clark; Madeline Werhane; Emily C Edmonds; Daniel A Nation; Nicole Evangelista; David J Libon; Mark W Bondi; Lisa Delano-Wood
Journal:  J Alzheimers Dis       Date:  2016-03-29       Impact factor: 4.472

10.  The Sub-Classification of Amnestic Mild Cognitive Impairment Using MRI-Based Cortical Thickness Measures.

Authors:  Pradeep Reddy Raamana; Wei Wen; Nicole A Kochan; Henry Brodaty; Perminder S Sachdev; Lei Wang; Mirza Faisal Beg
Journal:  Front Neurol       Date:  2014-05-21       Impact factor: 4.003

View more
  35 in total

1.  Neuropsychological latent classes at enrollment and postmortem neuropathology.

Authors:  Andrea R Zammit; Charles B Hall; David A Bennett; Ali Ezzati; Mindy J Katz; Graciela Muniz-Terrera; Richard B Lipton
Journal:  Alzheimers Dement       Date:  2019-08-13       Impact factor: 21.566

2.  Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment.

Authors:  Emily C Edmonds; Alexandra J Weigand; Kelsey R Thomas; Joel Eppig; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2018-09       Impact factor: 2.892

3.  Identifying the neural basis of a language-impaired phenotype of temporal lobe epilepsy.

Authors:  Erik Kaestner; Anny Reyes; Anna Christina Macari; Yu-Hsuan Chang; Brianna M Paul; Bruce P Hermann; Carrie R McDonald
Journal:  Epilepsia       Date:  2019-07-12       Impact factor: 5.864

4.  Early versus late MCI: Improved MCI staging using a neuropsychological approach.

Authors:  Emily C Edmonds; Carrie R McDonald; Anisa Marshall; Kelsey R Thomas; Joel Eppig; Alexandra J Weigand; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-02-06       Impact factor: 21.566

5.  Neuropsychological subtypes of incident mild cognitive impairment in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; Emily S Lundt; Sabrina M Albertson; Walter K Kremers; Michelle M Mielke; David S Knopman; Mark W Bondi; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2019-05-23       Impact factor: 21.566

6.  Word-list intrusion errors predict progression to mild cognitive impairment.

Authors:  Kelsey R Thomas; Joel Eppig; Emily C Edmonds; Diane M Jacobs; David J Libon; Rhoda Au; David P Salmon; Mark W Bondi
Journal:  Neuropsychology       Date:  2018-02       Impact factor: 3.295

Review 7.  Alzheimer's Disease: Past, Present, and Future.

Authors:  Mark W Bondi; Emily C Edmonds; David P Salmon
Journal:  J Int Neuropsychol Soc       Date:  2017-10       Impact factor: 2.892

8.  Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.

Authors:  Kelsey R Thomas; Emily C Edmonds; Lisa Delano-Wood; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2017-05-10       Impact factor: 2.892

9.  Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.

Authors:  Emily C Edmonds; Katherine J Bangen; Lisa Delano-Wood; Daniel A Nation; Ansgar J Furst; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

10.  Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kelsey R Thomas; Joel S Eppig; Alexandra J Weigand; Emily C Edmonds; Christina G Wong; Amy J Jak; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Steven D Edland; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2019-01-11       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.